Reference : External Quality Assessment of 24,25-dihydroxyvitamin D3 (24,25(OH)2D3) assays.
Scientific journals : Article
Human health sciences : Laboratory medicine & medical technology
External Quality Assessment of 24,25-dihydroxyvitamin D3 (24,25(OH)2D3) assays.
Carter, G. D. [> >]
Ahmed, F. [> >]
Berry, J. [> >]
Cavalier, Etienne mailto [Université de Liège - ULiège > Département de pharmacie > Chimie médicale >]
Durazo-Arvizu, R. [> >]
Gunter, E. [> >]
Jones, G. [> >]
Jones, J. [> >]
Phinney, K. [> >]
Sempos, C. T. [> >]
Twomey, P. J. [> >]
Williams, E. L. [> >]
Wise, S. A. [> >]
In press
The Journal of steroid biochemistry and molecular biology
Yes (verified by ORBi)
United Kingdom
[en] 24,25-Dihydroxyvitamin D ; 25-Hydroxyvitamin D ; 25-OHD(3):24,25(OH)(2)D(3) ratio ; DEQAS ; Hypercalcemia ; National Institute of Standards and Technology (NIST) ; Vitamin D Standardization Program (VDSP)
[en] The discovery that mutations of the CYP24A1 gene are a cause of idiopathic infantile hypercalcemia (IIH) has revived interest in measuring serum 24,25(OH)2D3. Several studies have also suggested that a high 25-hydroxyvitamin D3(25-OHD3):24,25(OH)2D3 ratio might provide additional diagnostic information in the investigation of vitamin D deficiency. Measurement of 24,25(OH)2D3 is necessarily restricted to laboratories with mass spectrometry methods although cross reactivity of the metabolite in immunoassays for 25-OHD is a potential cause of misleading results. The international External Quality Assessment (EQA) scheme for vitamin D metabolites (DEQAS) was set up in 1989. In 2013 DEQAS became an accuracy based EQA for 25-OHD with 'target values' assigned by the National Institute of Standards and Technology (NIST) Reference Measurement Procedure (RMP). A pilot scheme for serum 24,25(OH)2D3 was started in 2015 and participants were asked to measure the metabolite on each of the 5 samples sent out for 25-OHD. Inter-laboratory agreement was poor but this may reflect methodological differences, in particular different approaches to assay standardization. An important potential contribution to reducing variability among assays was the development by NIST of a 24,25(OH)2D3 RMP and its use in assigning values to SRMs 972a, 2973 and 2971, supported by the NIH Office of Dietary Supplements (ODS) as part of the Vitamin D Standardization Program (VDSP) effort.
Copyright (c) 2018 Elsevier Ltd. All rights reserved.

File(s) associated to this reference

Fulltext file(s):

Restricted access
1-s2.0-S0960076018305193-main.pdfPublisher postprint419.5 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.